SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 240 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $5,292,000 | +20.3% | 46,040 | +63.5% | 0.10% | +12.8% |
| Q3 2014 | $4,399,000 | -47.5% | 28,153 | -58.6% | 0.09% | -44.9% |
| Q2 2014 | $8,383,000 | -37.6% | 67,958 | -47.6% | 0.16% | -38.3% |
| Q1 2014 | $13,429,000 | -11.0% | 129,609 | -22.8% | 0.25% | -9.3% |
| Q4 2013 | $15,092,000 | +8.2% | 167,805 | -19.5% | 0.28% | +3.3% |
| Q3 2013 | $13,943,000 | +12.8% | 208,478 | +11.5% | 0.27% | +7.6% |
| Q2 2013 | $12,364,000 | – | 186,904 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
| OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
| SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
| Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
| Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
| HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
| CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
| Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |